Company: GSRF
Filing Date: 2025-06-20
Form Type: DRS
Source: 0001213900-25-056174
Chunk: 9

Company: GSR IV Acquisition Corp.
Filing Date: 2025-06-20
Form: DRS
Chunk 9
---
 -allotmentoption is exercised in full), in a private placement that will close simultaneously with the closing of this offering. If SPAC Advisory Partners participates in the private placement, GSR Sponsor will Confidential Treatment Requested by GSR IV Acquisition Corp.
Pursuant to 17 C.F.R. Section 200.83

reduce its purchase of private placement units by the corresponding number of private placement units purchased by SPAC Advisory Partners, provided that in no event will the private placement exceed 610,500 private placement units (or 655,500 private placement units if the underwriters exercise their over -allotmentoption in full). Subject to each sponsor member purchasing, through GSR Sponsor, the private placement units allocated to it in connection with the closing of this offering, GSR Sponsor will issue membership interests at a nominal purchase price to the sponsor members reflecting interests in an aggregate of Class B ordinary shares held by GSR Sponsor. None of the non -managingsponsor members shall have more than 9.9% interest in GSR Sponsor. Because our sponsor acquired the founder shares at a nominal price, our public shareholders will incur an immediate and substantial dilution upon the closing of this offering. The sponsor members will share in any appreciation of the founder shares through their membership interests in the sponsor if we successfully complete a business combination. Accordingly, sponsor members interests in the founder shares owned by them indirectly through their membership interests in the sponsor may provide them with an incentive to vote any public shares they own in favor of a business combination, and make a substantial profit on such interests, even if the business combination is with a target that ultimately declines in value and is not profitable for other public shareholders. Further, the issuance of additional ordinary or preference shares may significantly dilute the equity interest of public shareholders. See the sections titled “ Risk Factors — Risks Relating to GSR Sponsor and Management Team — Our initial shareholders paid an aggregate of $25,000 to cover certain of our offering costs in exchange for 5,750,000 founder shares, or approximately $0.004 per founder share and, accordingly, you will experience immediate and substantial dilution from the purchase of our Class A ordinary shares” and “Risk Factors — Risks Relating to Our Securities — The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and our sponsor is likely to make a substantial profit on its investment in us in